Beyond Healthcare Spending: The Evolving Definition Of Value In Health Policy

By Ana Amaris, MD, MPH, Director, Health Policy Initiatives, ISPOR

When a single policy is expected to deliver affordability, access, innovation, and supply resilience, a lower price or reduced payer spending no longer settles whether it worked.

Ana Amaris, MD, MPH, Director of Health Policy Initiatives at ISPOR, follows that tension across several health systems. She draws on a multidimensional value framework proposed in Canada, a Latin American analysis of the socioeconomic burden of disease, new US pricing agreements tied to domestic manufacturing, and South Korea's pricing and launch-sequencing questions. She then introduces the idea of realized value, which asks whether expected benefits materialize, for whom, and under what conditions.

For HEOR professionals, the central question is what evidence these decisions now require. Read the brief to see how the argument unfolds.